// App-Quantinova.ai

551 : Prediction of neoadjuvant chemotherapeutic efficacy by CTC and cfDNA in patients with locally advanced breast cancer.

Researchers

Presenter

  • Ge Ma

Principal Investigators

  • Jingyi Wang

  • Xiaoan Liu

  • Tiansong Xia

  • Shui Wang

Medical Centers

  • Second Affiliated Hospital of Dalian Medical University, Dalian, China

  • Jiangsu Cancer Hospital, Nanjing, China

  • Jiangsu Provincial Peoples Hospital (The First Affiliated Hospital of Nanjing Medical University), Nanjing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • Cluster of Differentiation 31

  • Cluster of differentiation 45

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved